Tumor Cell Invasion
|
phenotype |
|
Neoplastic Process
|
6626
|
169
|
0.060 |
None |
1.000 |
6 |
|
2011 |
2019 |
Blood Sedimentation
|
phenotype |
|
Laboratory Procedure
|
7
|
8
|
0.100 |
None |
1.000 |
2 |
2
|
2011 |
2012 |
Adult Erythroleukemia
|
disease |
|
Neoplastic Process
|
236
|
4
|
0.020 |
None |
1.000 |
2 |
|
1991 |
2000 |
C-reactive protein measurement
|
phenotype |
|
Laboratory Procedure
|
135
|
624
|
0.100 |
None |
1.000 |
1 |
39
|
2012 |
2012 |
Adult Acute Lymphocytic Leukemia
|
disease |
|
Neoplastic Process
|
860
|
154
|
0.010 |
None |
1.000 |
1 |
|
2000 |
2000 |
erythrocyte sedimentation rate result
|
phenotype |
|
Laboratory or Test Result
|
5
|
5
|
0.100 |
None |
1.000 |
1 |
1
|
2011 |
2011 |
C3 glomerulopathy
|
disease |
|
Disease or Syndrome
|
16
|
1
|
0.010 |
None |
< 0.001 |
1 |
|
2017 |
2017 |
Stage 0 Gallbladder Cancer AJCC v8
|
disease |
|
Neoplastic Process
|
367
|
56
|
0.010 |
None |
1.000 |
1 |
|
2009 |
2009 |
Stage IIA Gallbladder Cancer AJCC v8
|
disease |
|
Neoplastic Process
|
367
|
56
|
0.010 |
None |
1.000 |
1 |
|
2009 |
2009 |
Stage IIB Gallbladder Cancer AJCC v8
|
disease |
|
Neoplastic Process
|
367
|
56
|
0.010 |
None |
1.000 |
1 |
|
2009 |
2009 |
Stage III Gallbladder Cancer AJCC v8
|
disease |
|
Neoplastic Process
|
367
|
56
|
0.010 |
None |
1.000 |
1 |
|
2009 |
2009 |
Stage IV Gallbladder Cancer AJCC v8
|
disease |
|
Neoplastic Process
|
367
|
56
|
0.010 |
None |
1.000 |
1 |
|
2009 |
2009 |
Mental Depression
|
disease |
Behavior and Behavior Mechanisms
|
Mental or Behavioral Dysfunction
|
1478
|
271
|
0.010 |
None |
1.000 |
1 |
|
2012 |
2012 |
Depressed mood
|
phenotype |
Behavior and Behavior Mechanisms
|
Mental or Behavioral Dysfunction
|
1461
|
269
|
0.010 |
None |
1.000 |
1 |
|
2012 |
2012 |
Coronary Artery Disease
|
disease |
Cardiovascular Diseases
|
Disease or Syndrome
|
1708
|
1577
|
0.030 |
None |
1.000 |
3 |
2
|
2009 |
2019 |
Arteriosclerosis
|
disease |
Cardiovascular Diseases
|
Disease or Syndrome
|
2006
|
267
|
0.020 |
None |
1.000 |
2 |
1
|
2009 |
2009 |
Atherosclerosis
|
disease |
Cardiovascular Diseases
|
Disease or Syndrome
|
2044
|
281
|
0.020 |
None |
1.000 |
2 |
1
|
2009 |
2009 |
Cardiovascular Diseases
|
group |
Cardiovascular Diseases
|
Disease or Syndrome
|
1756
|
711
|
0.020 |
None |
1.000 |
2 |
|
2010 |
2017 |
Coronary Arteriosclerosis
|
disease |
Cardiovascular Diseases
|
Disease or Syndrome
|
1282
|
440
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Coronary heart disease
|
disease |
Cardiovascular Diseases
|
Disease or Syndrome
|
1576
|
1178
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Cardiomyopathies
|
group |
Cardiovascular Diseases
|
Disease or Syndrome
|
925
|
294
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Congenital glucose-galactose malabsorption
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Digestive System Diseases; Nutritional and Metabolic Diseases
|
Disease or Syndrome; Congenital Abnormality
|
19
|
12
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Elliptocytosis, Hereditary
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
23
|
1
|
0.020 |
None |
1.000 |
2 |
|
2008 |
2010 |
alpha-Thalassemia
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
86
|
37
|
0.010 |
None |
1.000 |
1 |
|
2004 |
2004 |
Cooley's anemia
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
144
|
19
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |